BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $472,632 | +0.6% | 66,756 | 0.0% | 0.09% | -2.1% |
Q2 2023 | $469,962 | -16.8% | 66,756 | -1.5% | 0.10% | -18.8% |
Q1 2023 | $565,085 | -27.0% | 67,756 | +0.5% | 0.12% | -28.7% |
Q4 2022 | $773,637 | -8.9% | 67,390 | 0.0% | 0.16% | -23.0% |
Q3 2022 | $849,000 | +19.6% | 67,390 | +0.5% | 0.21% | +27.5% |
Q2 2022 | $710,000 | -60.0% | 67,088 | -38.6% | 0.17% | -52.3% |
Q1 2022 | $1,775,000 | +17.4% | 109,188 | 0.0% | 0.35% | +23.7% |
Q4 2021 | $1,512,000 | -3.6% | 109,188 | 0.0% | 0.28% | -12.1% |
Q3 2021 | $1,569,000 | -11.2% | 109,188 | -2.2% | 0.32% | -11.0% |
Q2 2021 | $1,766,000 | +42.8% | 111,678 | -8.2% | 0.36% | +35.6% |
Q1 2021 | $1,237,000 | +57.8% | 121,678 | +15.7% | 0.27% | +37.6% |
Q4 2020 | $784,000 | – | 105,178 | +15.4% | 0.19% | – |
Q3 2020 | $0 | -100.0% | 91,178 | +10.3% | 0.00% | -100.0% |
Q2 2020 | $394,000 | +126.4% | 82,678 | -5.1% | 0.12% | +88.7% |
Q1 2020 | $174,000 | +58.2% | 87,078 | +172.1% | 0.06% | +93.8% |
Q4 2019 | $110,000 | – | 32,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |